Literature DB >> 320670

Topical clotrimazole in tinea pedis.

E B Smith, J L Graham, J A Ulrich.   

Abstract

Clotrimazole is a new antifungal agent which is effective topically in dermatophytosis, cutaneous candidiasis, and tinea vesicolor. The authors performed a controlled double-blind clinical trial comparing topical clotrimazole with its vehicle in the treatment of 66 patients with dermatophytic infections of the skin of the feet. Clotrimazole proved to be effective in the treatment of tinea pedis of both the interdigital and the plantar hyperkeratotic types.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 320670     DOI: 10.1097/00007611-197701000-00021

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

1.  In vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imidazole antimycotic agent.

Authors:  Y Niwano; N Kuzuhara; H Kodama; M Yoshida; T Miyazaki; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Systematic review of topical treatments for fungal infections of the skin and nails of the feet.

Authors:  R Hart; S E Bell-Syer; F Crawford; D J Torgerson; P Young; I Russell
Journal:  BMJ       Date:  1999-07-10

Review 3.  Pharmacoeconomic analysis of topical treatments for tinea infections.

Authors:  N H Shear; T R Einarson; S R Arikian; J J Doyle
Journal:  Pharmacoeconomics       Date:  1995-03       Impact factor: 4.981

4.  Evidence based general practice: a retrospective study of interventions in one training practice.

Authors:  P Gill; A C Dowell; R D Neal; N Smith; P Heywood; A E Wilson
Journal:  BMJ       Date:  1996-03-30

Review 5.  Topical treatments for fungal infections of the skin and nails of the foot.

Authors:  F Crawford; S Hollis
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 6.  Deep learning: new computational modelling techniques for genomics.

Authors:  Gökcen Eraslan; Žiga Avsec; Julien Gagneur; Fabian J Theis
Journal:  Nat Rev Genet       Date:  2019-07       Impact factor: 53.242

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.